Cognition Therapeutics Inc [CGTX] stock prices are down -0.62% to $0.63 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CGTX shares have gain 31.82% over the last week, with a monthly amount glided 43.20%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cognition Therapeutics Inc [NASDAQ: CGTX] stock has seen the most recent analyst activity on December 19, 2024, when B. Riley Securities upgraded its rating to a Buy and also boosted its price target to $1.50 from $1. Previously, Cantor Fitzgerald downgraded its rating to Neutral on July 30, 2024. On November 03, 2021, Oppenheimer initiated with a Outperform rating and assigned a price target of $22 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $27 on November 03, 2021.
The stock price of Cognition Therapeutics Inc [CGTX] has been fluctuating between $0.34 and $2.95 over the past year. Cognition Therapeutics Inc [NASDAQ: CGTX] shares were valued at $0.63 at the most recent close of the market.
Analyzing the CGTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -157.08%, Pretax Profit Margin comes in at -92.12%, and Net Profit Margin reading is -92.12%. To continue investigating profitability, this company’s Return on Assets is posted at -1.24, Equity is -1.51 and Total Capital is -3.93. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5809 points at the first support level, and at 0.5317 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6784, and for the 2nd resistance point, it is at 0.7267.
Ratios To Look Out For
It’s worth pointing out that Cognition Therapeutics Inc [NASDAQ:CGTX]’s Current Ratio is 2.11. On the other hand, the Quick Ratio is 2.11, and the Cash Ratio is 1.73.
Transactions by insiders
Recent insider trading involved Ricciardi Lisa, CEO & President, that happened on Mar 14 ’24 when 5700.0 shares were purchased.
